From Bench to Bedside: Navigating the Regulatory Path of Therapeutic Development
Hosted by JHTV & Blackbird Labs
Join us for a seminar about the regulatory path for therapeutics and moving them from the lab to the clinic, led by industry expert Jonathan Helfgott. Attendees are encouraged to submit topics you want us to cover so we can tailor the seminar content to your interests. Snacks and refreshments will be served.
RECOMMENDED ATTENDEES
Johns Hopkins faculty members
ATTEND TO LEARN
- Requirements for new drug testing on patients
- Types of regulatory interactions with the FDA
- Contents of an Investigational New Drug submission
EVENT DETAILS
- March 27 | 2-4 p.m.
- JHTV Innovation Hub
1812 Ashland Ave., Suite 110
Baltimore, MD 21205
About Jonathan Helfgott
Co-Founder, Client Engagement | Healthcare Innovation Catalysts
With almost 20 years of combined experience at FDA, academia, and private industry, Jonathan Helfgott supports the commercialization of medical products at all phases of development. In his career, he has held various senior-management positions such as President and Executive Director responsible for managing and overseeing global clinical research & regulatory teams and activities, including overall product development, approvals, submissions, clinical trial design/conduct, inspections, and communications with health authorities and payors.
Space is limited – RSVP today!